NASDAQ · Biotechnology

Liquidia Corporation (LQDA) Stock

$42.65 +7.46% NASDAQ: LQDA Healthcare

Valuation

MetricValue
Price$42.65
Market Cap$3.82B
P/E Ratio19.28
P/B Ratio13.79
P/S Ratio5.97
EPS (TTM)$-0.80
52-Week High$93.61
52-Week Low$21.35
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE149.64%
ROA26.56%
ROCE50.68%
Gross Margin98.72%
Operating Margin15.81%
Net Margin30.74%
Debt/Equity0.66
Current Ratio2.01

Annual Financials (USD)

Metric20212022202320242025
Revenue$13.0M$16.0M$17.0M$14.0M$158.0M
Operating Profit$-34.0M$-39.0M$-73.0M$-121.0M$-51.0M
Net Profit$-35.0M$-41.0M$-79.0M$-130.0M$-69.0M
EPS$-0.70$-0.67$-1.21$-1.66$-0.80
Op Margin-262.9%-243.3%-419.6%-866.6%-32.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$94.0M$129.0M$118.0M$230.0M$328.0M
Total Liabilities$28.0M$39.0M$71.0M$153.0M$283.0M
Cash$57.0M$93.0M$84.0M$176.0M$191.0M
Borrowings$16.0M$24.0M$50.0M$122.0M$198.0M

Latest News

Here's Why You Should Add INKT Stock to Your Portfolio Now Zacks · Jul 16, 2026 Axsome's NDA for AXS-12 in Narcolepsy Gets FDA Acceptance Zacks · Jul 16, 2026 Summit to Divest Late-Stage Antibiotic Drug to Biossil in $105M Deal Zacks · Jul 15, 2026 Liquidia Insider Sold Shares Worth $2,520,683, According to a Recent SEC Filing MT Newswires · Jul 15, 2026 Liquidia Insider Sold Shares Worth $1,460,965, According to a Recent SEC Filing MT Newswires · Jul 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-34.0M$-29.0M$-42.0M$-93.0M$-36.0M
Investing Cash Flow$0$-1.0M$-13.0M$-13.0M$-11.0M
Financing Cash Flow$5.0M$2.0M$0$4.0M$1.0M
Net Cash Flow$-8.0M$36.0M$-10.0M$93.0M$14.0M
Free Cash Flow$-34.0M$-29.0M$-43.0M$-98.0M$-40.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA14.26
FCF Yield2.25%
Quick Ratio2.12
Interest Coverage6.33
Return 1Y138.07%
Return 3Y882.26%
Return 5Y2443.07%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AVLNAvalyn Pharma Inc. $26.04 -4.44% -20.19 $1.15B 0.00%
INSMInsmed Incorporated $93.39 -1.76% -28.13 $20.39B 0.00%
UTHRUnited Therapeutics Corporation $587.50 +0.46% 17.74 $25.20B 0.00%
VCREVicore Pharma Holding AB $8.82 +1.85% -9.33 $2.48B 0.00%

About Liquidia Corporation

Liquidia Corporation is led by CEO Roger A. Jeffs, employs 216 people, headquartered in Morrisville, US, publicly traded since 2018.

Liquidia Corporation (LQDA) stock trades at $42.65 with a market capitalization of $3.82B. The stock is valued at a price-to-earnings (P/E) ratio of 19.28, price-to-book of 13.79, price-to-sales of 5.97. Over the past 52 weeks the stock has ranged between $21.35 and $93.61, and currently trades 54.4% below its 52-week high.

On profitability, Liquidia Corporation generates a return on equity (ROE) of 149.64%, above the typical market range of roughly 12-15%, return on capital employed of 50.68%, an operating margin of 15.81%, a net profit margin of 30.74%.

Liquidia Corporation by the numbers, 2016–2025

Between 2016 and 2025 Liquidia Corporation reported revenue of $13.0M rising to $158.0M, a change of +1115.4% across 10 years. Compounded, revenue has grown 175.3% a year over five years, 114.5% over three, 1028.6% over the last twelve months. Net profit fell to $-69.0M.

Operating margin went from -120.0% in 2016 to -32.5% in 2025, a gain of 87.6 percentage points. The most recent net margin is 30.74%. On a trailing twelve-month basis to Jun '26, revenue is $451.0M and net profit $139.0M.

Borrowings rose from $9.0M to $198.0M, cash from operations was $-36.0M in the latest year, positive in 0 of the last 10.

Return on equity has averaged -117.9% over five years, and was -153.3% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Liquidia Corporation (LQDA) — frequently asked questions

What is Liquidia Corporation (LQDA) stock price today?

Liquidia Corporation (LQDA) is currently trading at $42.65, up 7.46% today.

What is LQDA P/E ratio?

Liquidia Corporation's P/E ratio is 19.28. This is between 15x and 30x, around the typical market average of roughly 18-22x.

What is LQDA return on equity (ROE)?

Liquidia Corporation's return on equity (ROE) is 149.64%. ROE measures net income relative to shareholders' equity. This is above the typical market range of roughly 12-15%.

What is Liquidia Corporation's market cap?

Liquidia Corporation has a market capitalization of $3.82B.

Does LQDA pay a dividend?

Liquidia Corporation is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does LQDA carry?

Liquidia Corporation has a debt-to-equity ratio of 0.66. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is LQDA's profit margin?

Liquidia Corporation reports a net profit margin of 30.74% — the share of revenue left after every cost, including tax and interest.

What sector is LQDA in?

Liquidia Corporation is classified under Healthcare, in the Biotechnology industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is LQDA listed on?

Liquidia Corporation trades on NASDAQ under the ticker LQDA.

What is LQDA's 52-week range?

Over the last year Liquidia Corporation has traded between $21.35 and $93.61.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens LQDA currently matches

On the figures above, Liquidia Corporation passes the filters for 19 of our ready-made screens, among them High ROE Stocks, Quality Stocks, High Profit Margin Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

High ROE StocksQuality StocksHigh Profit Margin StocksHigh ROA StocksCompanies With Highest ROEDay Gainers StocksHealthcare Stocks To BuyFree Stock Screener PicksStocks With PE Under 20High ROCE StocksStocks Under $100Stocks Under $50High Gross Margin StocksMid Cap StocksStocks With PE Under 25Stocks With PE Under 30High ROE Stocks Under $100Debt to Equity Below 1 StocksHigh Current Ratio Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.